Monitor for future filings disclosing the terms of the Series B Preferred Stock offering, including size, pricing, and use of proceeds, which could impact equity dilution and company valuation.
Price Chart
Executive Summary
SRx Health Solutions obtained waivers from existing investors to proceed with a new preferred stock offering (Series B), allowing the company to issue new securities and waive existing participation rights. The Series B Preferred Stock will rank pari passu with the existing Series A Preferred Stock in terms of dividend and liquidation preferences.
Key Financial Metrics
Key Facts
- SRx Health Solutions entered into limited waiver and consent agreements with existing investors to permit a new securities offering (New Offering).
- The New Offering involves the issuance of Series B Preferred Stock and related warrants to new accredited investors.
- Existing investors waived their right of participation in the New Offering and any subsequent placements.
- Certain existing investors, as Required Holders, consented to the Series B Preferred Stock ranking pari passu with the Series A Preferred Stock regarding dividends, distributions, and liquidation preferences.
- No financial terms of the New Offering (e.g., size, price, valuation) were disclosed in this filing.
Financial Impact
Potential future capital raise via Series B Preferred Stock offering, but no financial terms disclosed.
Risk Factors
- Future dilution to common shareholders upon issuance of Series B Preferred Stock and exercise of related warrants.
- Potential for unfavorable terms in the New Offering that may not be disclosed until closing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-008656 |
| Exhibit: ex10-1.htm | 0001493152-26-008656 |
| Document: 0001493152-26-008656-index-headers.html | 0001493152-26-008656 |
| Document: 0001493152-26-008656-index.html | 0001493152-26-008656 |
| Document: 0001493152-26-008656.txt | 0001493152-26-008656 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 9, 2026 23d ago | 8-K | $1.51 $1.60 | ▲ +5.96% | ▲ +6.62% | $1.61 (+6.62%) |
Sep 2, 2026 4w ago | 8-K | $1.56 $1.59 | ▲ +1.92% | ▲ +3.07% | $1.61 (+3.21%) |
Aug 28, 2026 5w ago | 8-K | $1.68 $1.59 | ▲ +5.65% | ▲ +5.51% | $1.61 (+4.17%) |
Aug 19, 2026 6w ago | 8-K | $1.87 $1.84 | ▼ −1.60% | ▼ −1.22% | $1.61 (−13.90%) |
Aug 4, 2026 8w ago | Press Release | $1.37 $1.84 | ▲ +34.31% | ▲ +34.41% | $1.61 (+17.52%) |
Aug 3, 2026 8w ago | Press Release | $1.44 $1.73 | ▲ +20.14% | ▲ +18.11% | $1.61 (+11.81%) |
Jul 30, 2026 9w ago | Press Release | $1.48 $1.43 | ▼ −3.38% | ▼ −7.00% | $1.61 (+8.78%) |
Jul 28, 2026 9w ago | 8-K | $1.48 $1.44 | ▲ +2.70% | ▲ +4.97% | $1.61 (−8.78%) |
Jul 16, 2026 11w ago | 8-K | $2.41 $1.80 | ▼ −25.31% | ▼ −23.64% | $1.61 (−33.20%) |
Jul 16, 2026 11w ago | Press Release | $2.41 $1.80 | ▼ −25.31% | ▼ −23.64% | $1.61 (−33.20%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access